Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

White House Submits Sotomayor's Questionnaire To Senate Judiciary Committee
The Senate Judiciary Committee"s vetting of Judge Sonia Sotomayor, President Obama"s nominee for the Supreme Court, officially began Thursday when the White House delivered her written responses to a comprehensive questionnaire designed by the committee"s leadership, Roll Call reports. The questionnaire -- developed by Committee Chair Patrick Leahy (D-Vt.) and ranking member Jeff Sessions (R-Ala.) -- will be used as part of preparations for Sotomayor"s as-yet-unscheduled round of confirmation hearings (Stanton, Roll Call, 6/4).Sotomayor disclosed a large amount of information in the questionnaire, such as her net worth and a timeline for when she learned that she was under consideration by the White House as a potential replacement to retiring Supreme Court Justice David Souter (Perine, CQ Today, 6/4). According to Roll Call, Sotomayor"s responses might offer members of both parties "fodder to support or oppose her nomination."Leahy, who has the authority to schedule the confirmation hearings, said in a statement that Sotomayor "has advanced the confirmation process by promptly complying with this Senate requirement, and now the Senate should promptly schedule hearings to fairly consider her nomination to our highest court," adding, "The unfair attacks that have been leveled at her from outside the Senate are all the more reason to give her the chance to respond." Earlier this week, he said that he would announce a start date for the hearings after Sotomayor"s responses were received (Roll Call, 6/4). Meanwhile, Sotomayor on Thursday continued another round of private meetings with senators on Capitol Hill, including a few GOP senators who earlier had expressed concerns about her past comments and actions, CQ Today reports (CQ Today, 6/4).Questions Over Sotomayor"s Position on Abortion-Rights Issue RemainIn related news, USA Today on Friday examined how Sotomayor in the past 17 years as a federal judge "has left no clear footprints revealing" her position on abortion-rights issues. This week, some Democratic senators in private meetings with Sotomayor attempted to seek answers, while advocates on both sides of the debate are urging senators to question her about her views on Roe v. Wade during the expected confirmation hearings. On Wednesday, following a meeting with Sotomayor, Sen. Dianne Feinstein (D-Calif.) said that she believes Sotomayor has respect for judicial precedent. Nancy Northup, president of the Center for Reproductive Rights, said, "I don"t have concerns about this nominee in the sense that I think there is something on the record (against abortion rights)," adding, "We just think it"s important for Supreme Court nominees to say where they stand." Charmaine Yoest, president of Americans United for Life, agreed, noting the lack of a definitive position on abortion rights in Sotomayor"s record. Feinstein also said that she will persist on abortion-rights issues. "I remember what it was like when abortion was illegal, and the lives of young, desperate women were in jeopardy," she said, adding that she is concerned "Americans no longer appreciate what it would mean if (abortion rights) were taken away" (Biskupic, USA Today, 6/5).
generic viagra online
Pneumococcal Vaccine Reduces Child Deaths In Developing Countries
A new trial has found that pneumococcal vaccine is effective in preventing severe pneumonia, the leading cause of death among children in developing countries. Co-ordinated by the National Institute for Health and Welfare (THL) between 2000 and 2004, a large scale efficacy trial first of its kind in Asia - was carried out in the Philippines to investigate the effect of an investigational pneumococcal vaccine.
News of the day
Possible Link Between Pregnancy, The Flu And Schizophrenia
When mothers become infected with influenza during their pregnancy, it may increase the risk for schizophrenia in their offspring. Influenza is a very common virus and so there has been substantial concern about this association. A new study in the June 15th issue of Biological Psychiatry, published by Elsevier suggests that the observed association depends upon a pre-existing vulnerability in the fetus.
Health Insurance

Application Of Innovative Laser Research Could Lead To Earlier Bone Disorder Diagnosis

A new laser technique that could lead to bone disorders being diagnosed earlier is to be tested in a hospital for the first time. The study, which it"s hoped will pave the way for future clinical trials, will apply a revolutionary approach known as SORS (Spatially Offset Raman Spectroscopy), to examine specific substances in non see-through surfaces deeper than has previously been possible, without damaging the surface. The research team hope ultimately that the method can be used both to detect and screen for early signs of diseases such as osteoarthritis and osteoporosis. "This exciting new approach has been developed by combining expertise in multidisciplinary research collaboration over a number of years. This has now culminated in a system for minimally invasive assessment of skeletal tissues and could with further development - form the basis of a rapid safe economical screening system for musculoskeletal disease", said Professor Allen Goodship (UCL), the project Principal Investigator. The basic technique, devised and patented in the Central Laser Facility at the Science and Technology Facilities Council (STFC), was developed for this application through an ongoing collaboration with the Institute of Orthopaedics and Musculoskeletal Science, University College London (UCL). The concept has been evaluated on bone samples with differing chemical composition but never before in a hospital on patients - as will happen in the next few years. Professor Pavel Matousek who is an STFC physicist and an honorary Professor at UCL is the lead inventor of the technique, he says; "The new method effectively suppresses otherwise blinding interfering signals from skin, making it possible to see subtle chemical changes within all the components of bone through the skin, without the need for a biopsies. The new approach is also able to provide far more information than conventional X-ray based systems that are limited to the mineral components only. The data can be related to the chemistry of bone tissue in its entirety and the analytical chemistry side of the work is supported by STFC"s Professor Tony Parker, head of the Lasers for Science Facility at the Central Laser Facility and also an honorary Professor at UCL. This translational phase of the research has been made possible by a ÷£1.7 million grant awarded by the Engineering and Physical Sciences Research Council (EPSRC) and through an ongoing partnership with UCL which demonstrated the feasibility of applying this technology to bone composition and with the Royal National Orthopaedic Hospital (RHOH) in Stanmore, Middlesex where the trials will take place. ""This project adds to the ongoing role of the RNOH to lead in innovative approaches to the management of complex musculoskeletal disease. This project has the potential to provide a means of detection and confirmation of some of the rare bone disorders that are still difficult to diagnose. It could make significant contributions to reducing the burden of musculoskeletal disease and associated chronic pain experienced by these patients"" said Dr Richard Keen, a co-investigator and consultant rheumatologist at RNOH. Whilst the technique is promising, it has to be fully understood. If these trials are successful it may take several years for the method to become fully realised for diagnostic use in the mainstream health service. Notes SORS bone spectroscopy technique was developed as part of an ongoing project between STFC, UCL and RNOH. The SORS technique has also been developed for pharmaceutical and security applications. These applications are in more advanced stages and are presently taken forward through STFC"s spin-out company Cobalt Light Systems Ltd. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government"s most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is in the top ten world universities in the 2008 THES-QS World University Rankings, and the third-ranked UK university in the 2008 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Marie Stopes, Jonathan Dimbleby, Lord Woolf, Alexander Graham Bell, and members of the band Coldplay. http://www.ucl.ac.uk Royal National Orthopaedic Hospital The Royal National Orthopaedic Hospital (RNOH) is the largest specialist tertiary orthopaedic referral centre in the UK and a world-renowned specialist hospital for the diagnosis and treatment of complex neuro-musculoskeletal conditions. These range from the most acute spinal injuries, bone tumours and complex joint reconstruction to orthopaedic medicine for metabolic bone diseases andspecialist rehabilitation for those with conditions ranging from severe spinal cord injury to chronic back pain. Engineering and Physical Sciences Research Council (EPSRC) The Engineering and Physical Sciences Research Council (EPSRC) is the UK"s main agency for funding research in engineering and the physical sciences. The EPSRC invests more than ÷£800 million a year in research and postgraduate training to tackle the challenges of the 21st Century. http://www.epsrc.ac.uk Central Laser Facility The STFC"s Central Laser Facility is a partnership between its staff and the large number of members of UK and European universities who use the specialised laser equipment provided to carry out a broad range of experiments in physics, chemistry and biology. Cobalt Light Systems Cobalt Light Systems Ltd is a UK company and sole provider of SORS products and technology. Cobalt develops instruments and applications for pharmaceutical assay, formulation development and quality control and also works with organisations to develop products in other markets such as medical, security and counterfeit detection. Science and Technology Facilities Council The Science and Technology Facilities Council ensures the UK retains its leading place on the world stage by delivering world-class science; accessing and hosting international facilities; developing innovative technologies; and increasing the socio-economic impact of its research through effective knowledge exchange partnerships. The Council has a broad science portfolio including Astronomy, Particle Physics, Particle Astrophysics, Nuclear Physics, Space Science, Synchrotron Radiation, Neutron s and High Power Lasers. In addition the Council manages and operates three internationally renowned laboratories: - The Rutherford Appleton Laboratory, Oxfordshire - The Daresbury Laboratory, Cheshire - The UK Astronomy Technology Centre, Edinburgh The Council gives researchers access to world-class facilities and funds the UK membership of international bodies such as the European Laboratory for Particle Physics (CERN), the Institute Laue Langevin (ILL), European Synchrotron Radiation Facility (ESRF), the European organisation for Astronomical Research in the Southern Hemisphere (ESO) and the European Space Agency (ESA). It also contributes money for the UK telescopes overseas on La Palma, Hawaii, Australia and in Chile, and the MERLIN/VLBI National Facility, which includes the Lovell Telescope at Jodrell Bank Observatory. Science and Technology Facilities Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009